8 news items
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
IVVD
7 May 24
adintrevimab, Invivyd's investigational mAb that has a robust safety data package and provided evidence of clinical efficacy in global Phase 2/3 clinical
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
IVVD
15 Apr 24
investigational mAb that has a robust safety data package and provided evidence of clinical efficacy in a global Phase 2/3 clinical trial for the prevention
Invivyd Announces CEO Transition
IVVD
12 Apr 24
was engineered from adintrevimab, Invivyd's investigational mAb that has a robust safety data package and provided evidence of clinical efficacy
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
IVVD
4 Apr 24
was engineered from adintrevimab, Invivyd's investigational mAb that has a robust safety data package and provided evidence of clinical efficacy
FDA Gives Emergency Use Nod To Invivyd's Antibody To Prevent COVID-19 Infection In Adults, Adolescents With Weak Immune System
IVVD
25 Mar 24
are expecting to have product available for order imminently, with initial supply already packaged and awaiting final release at our U.S.-based third-party
qf4yokncerg3nvzicktcz2u0hpy8qzqzwvsvmo48ivvl7 bg6wm
IVVD
22 Mar 24
a robust safety data package and demonstrated clinically meaningful results in global Phase 2/3 clinical trials for both the prevention and treatment
f90gn1fujsv8xey 4vh4w5t28s7r16
IVVD
22 Mar 24
trial of our mAb now known as PEMGARDA, we are expecting to have product available for order imminently, with initial supply already packaged
ec6 r14d7jaw
IVVD
22 Mar 24
mAb now known as PEMGARDA, we are expecting to have product available for order imminently, with initial supply already packaged and awaiting final
- Prev
- 1
- Next